| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-03-03 | Amag Pharmaceuticals (USA - MA) | $ 201 million (€ 179.8 million) | private placement | Private placement | ||
| 2015-03-02 | GenePOC (Canada) | undisclosed | financing round | Debiopharm Diagnostics (Switzerland) Emerillon Capital (Canada) | Infectious diseases - Diagnostic | Financing round |
| 2015-03-02 | Xencor (USA - CA) | $122.9 million | private placement | Allergic diseases - Autoimmune diseases - Respiratory diseases - Cancer - Oncology | Private placement | |
| 2015-03-01 | DiViNe consortium (Affilogic (France) Aquaporin (Denmark), GenIbet Biopharmaceuticals (Portugal) GSK (UK) iBET (Portugal) Merck KGaA (Germany) | €5.8 million | grant | European Commission’s Horizon 2020 programme | Infectious diseases - Technology - Services | Grant |
| 2015-02-27 | Celyad previously known as Cardio3 Biosciences (Belgium) | € 32 million | private placement | Cardiovascular diseases - Cancer - Oncology | Private placement | |
| 2015-02-27 | Celldex Therapeutics (USA - NJ) | $24.7 million | private placement | Cancer - Oncology | Private placement | |
| 2015-02-24 | Prexton Therapeutics (Switzerland) | €8.7 million ($10 million) | series A financing round | Sunstone Capital (Denmark) Ysios Capital (Spain) MS Ventures (Germany) | CNS diseases - Neurodegenerative diseases | Series A financing round |
| 2015-02-23 | The University of Manchester (UK) Cobra Biologics (Sweden) | £217 000 | grant | Innovate UK (UK) | Technology - Services | Grant |
| 2015-02-20 | Neurovive Pharmaceutical (Sweden) | SEK 65 million (€ 6.8 million) | private placement | Cardiovascular diseases | Private placement | |
| 2015-02-19 | VolitionRx (Singapore) | private placement | Cancer - Oncology - Infectious diseases - Diagnostic | Private placement | ||
| 2015-02-18 | Horizon Discovery (UK) | £1.67 million | grant | Innovate UK (UK) Biotechnology and Biological Sciences Research Council (BBSRC) (UK) | Technology - Services | Grant |
| 2015-02-17 | Quantum Genomics (France) | €11.2 million | capital increase | Cardiovascular diseases | Capital increase | |
| 2015-02-15 | Poxel (France) | € 25 million | IPO | Metabolic diseases | IPO | |
| 2015-02-12 | AC Immune (Switzerland) | undisclosed | grant | The Michael J. Fox Foundation - MJFF (USA) | Neurodegenerative diseases | Grant |
| 2015-02-11 | Bone Therapeutics (Belgium) | €37 million | IPO | Bone diseases - Regenerative medicine | IPO | |
| 2015-02-11 | Cortendo (Sweden) | $26.4 million | private placement | RA Capital Management (USA - MA), New Enterprise Associates (NEA) (USA - MD), Broadfin Capital (USA - NY) HealthCap (Sweden) | Rare diseases | Private placement |
| 2015-02-11 | Galapagos (Belgium) | €1.6 million | grant | Flemish Agency for Innovation by Science and Technology (IWT) (Belgium) | Infectious diseases | Grant |
| 2015-02-10 | Inoviem Scientific (France) | € 0.5 million | financing round | Cap Innov’Est (France) | Technology - Services | Financing round |
| 2015-02-09 | Innovacell (Austria) | € 3 million | capital increase | Capital increase | ||
| 2015-02-09 | Melinta Therapeutics (USA - CT) | $30 million | loan | Hercules Technology Growth Capital (USA - CA) | Infectious diseases | Loan |
